A New Venture Begins: Introducing Translational Cures??

As I step into my next chapter, I’m filled with a deep sense of gratitude and excitement. Not long ago, I concluded one meaningful journey, and now, with renewed spirit, I’m thrilled to share that I have founded Translational Cures, LLC (TranslationalCures.com), a translational science strategy and digital CRO (contract research organization).

This new endeavor feels like the natural evolution of my career, as I plan to continue translating groundbreaking science into practical solutions that drive public health forward.

At Translational Cures , we’re dedicated to creating customized, actionable regulatory strategies that blend translational science, human expertise, and AI to accelerate new cures for patients. With innovative laboratory methods like human organ-on-a-chip and advanced digital technologies like AI and computational modeling, we’re opening doors to determine the effectiveness of drugs for rare diseases—without requiring large clinical trials. Our solutions aim to offer effective alternatives to animal testing, advancing these breakthroughs into regulatory use.

To learn more, please visit us at TranslationalCures.com. We’re excited to connect and explore how you might engage or partner with us on this journey!